[144] REGIS CORP SEC Filing

Rhea-AI Filing Summary

Form 144 filed for Regis Corporation (RGS) reports a proposed sale of 9,626 shares of Common stock through Fidelity Brokerage Services with an aggregate market value of $278,342.33. The filing lists approximately 2,435,981 shares outstanding and an approximate sale date of 09/18/2025. The securities are shown as acquired in connection with an option (grant date 05/05/2022) and the indicated acquisition date is 09/18/2025; the consideration on sale is listed as cash. The filer states there were no securities sold by the person in the past three months and signs the required attestation that they are not aware of any undisclosed material adverse information about the issuer.

Insights

Securities Analyst

TL;DR: Routine Form 144 disclosing an insider sale of 9,626 shares valued at $278,342.33; appears procedural rather than material.

The notice documents a proposed sale under Rule 144 via Fidelity Brokerage Services with the seller reporting acquisition via an option grant and payment to be in cash. The disclosed amount represents a small portion of the issuer's reported outstanding shares (9,626 versus 2,435,981). The filing also confirms no reported sales by the person in the prior three months and includes the standard attestation about material nonpublic information. Based solely on the filing's content, this is a routine insider disposition notice and does not by itself indicate operational or financial changes at the company.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure of a proposed sale under Rule 144; attestation included, no governance red flags disclosed.

The form supplies the broker, share count, aggregate value, outstanding shares, and sale timing required for transparency under Rule 144. It notes acquisition via an option grant with an option grant date provided. The signer affirms absence of undisclosed material adverse information, consistent with required certifications. There are no indications in the document of accelerated insider selling patterns or governance concerns disclosed within this single filing.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	9626	278342.33	2435981	09/18/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/18/2025	Option Granted - 05/05/2022	Issue			9626	09/18/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for Regis Corporation (RGS) disclose?

It discloses a proposed sale of 9,626 common shares through Fidelity Brokerage Services with an aggregate market value of $278,342.33 and an approximate sale date of 09/18/2025.

How many shares does the filing say are outstanding for RGS?

The filing lists 2,435,981 shares outstanding for the class referenced in the notice.

How were the securities acquired according to the filing?

The securities are reported as acquired via an option grant (option grant date 05/05/2022) with an acquisition date shown as 09/18/2025.

Does the filer report any sales in the past three months?

No. The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

What certification does the filer make on the form?

The filer attests they do not know of any material adverse information regarding the issuer that has not been publicly disclosed, and references the Rule 10b5-1 plan language if applicable.